AP
CLB icon

AHL Partners’s Core Laboratories CLB Stock Holding History

AHL Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,961
Closed -$835K – 1185
2016
Q4 		$835K Buy
6,961
+2,472
+55% +$274K 0.03% 702
2016
Q3 		$504K Sell
4,489
-567
-11% -$65.3K 0.02% 836
2016
Q2 		$626K Buy
5,056
+1,868
+59% +$226K 0.03% 556
2016
Q1 		$359K Buy
3,188
+528
+20% +$54.9K 0.02% 635
2015
Q4 		$289K Sell
2,660
-56
-2% -$6.41K 0.02% 621
2015
Q3 		$271K Buy
2,716
+564
+26% +$61.3K 0.04% 592
2015
Q2 		$245K Buy
+2,152
New +$261K 0.01% 795

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

AHL Partners's CLB Position: Q1 2017 in Review

AHL Partners sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 6,961 shares — an estimated $835K sold.

AHL Partners first reported a position in CLB in Q2 2015 and held it in 7 quarters. The position peaked at $835K in Q4 2016. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

  • AHL Partners reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
  • AHL Partners sold 6,961 Core Laboratories shares in Q1 2017, an estimated $835K.
  • AHL Partners first reported a position in Core Laboratories in Q2 2015 and held it in 7 quarters.
  • AHL Partners's Core Laboratories position peaked at $835K in Q4 2016.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on AHL Partners's 13F filing for Q1 2017, filed 15 May 2017.